FI895831A0 - Foerfarande foer framstaellning av (d)-6-fluor-2,3-dihydro-2',5'-dioxo-spiro/4h-1-benzopyran-4,4' -imidazolin/-2-karboximidderivat. - Google Patents

Foerfarande foer framstaellning av (d)-6-fluor-2,3-dihydro-2',5'-dioxo-spiro/4h-1-benzopyran-4,4' -imidazolin/-2-karboximidderivat.

Info

Publication number
FI895831A0
FI895831A0 FI895831A FI895831A FI895831A0 FI 895831 A0 FI895831 A0 FI 895831A0 FI 895831 A FI895831 A FI 895831A FI 895831 A FI895831 A FI 895831A FI 895831 A0 FI895831 A0 FI 895831A0
Authority
FI
Finland
Prior art keywords
framstation
benzopyran
imidazoline
dioxo
spiro
Prior art date
Application number
FI895831A
Other languages
English (en)
Inventor
Masayasu Kurono
Toshinao Usui
Yasuaki Kondo
Kenji Miura
Kiichi Sawai
Original Assignee
Sanwa Kagaku Kenkyusho Co Co L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanwa Kagaku Kenkyusho Co Co L filed Critical Sanwa Kagaku Kenkyusho Co Co L
Publication of FI895831A0 publication Critical patent/FI895831A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI895831A 1988-04-07 1989-12-05 Foerfarande foer framstaellning av (d)-6-fluor-2,3-dihydro-2',5'-dioxo-spiro/4h-1-benzopyran-4,4' -imidazolin/-2-karboximidderivat. FI895831A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8409888 1988-04-07
JP63298220A JP2708507B2 (ja) 1988-04-07 1988-11-28 （ｄ）‐６‐フルオロ‐２，３‐ジヒドロ‐２’，５’‐ジオキソ‐スピロ［４Ｈ‐１‐ベンゾピラン‐４，４’‐イミダゾリジン］‐２‐カルボキサミド誘導体、これらの製法及び用途
PCT/JP1989/000369 WO1989009773A1 (en) 1988-04-07 1989-04-06 (d)-6-FLUORO-2,3-DIHYDRO-2',5'-DIOXO-SPIRO[4H-1-BENZOPYRAN-4,4'-IMIDAZOLIDINE]-2-CARBOXAMIDE DERIVATIVES, MANUFACTURING PROCESS AND USE THEREOF

Publications (1)

Publication Number Publication Date
FI895831A0 true FI895831A0 (fi) 1989-12-05

Family

ID=26425177

Family Applications (1)

Application Number Title Priority Date Filing Date
FI895831A FI895831A0 (fi) 1988-04-07 1989-12-05 Foerfarande foer framstaellning av (d)-6-fluor-2,3-dihydro-2',5'-dioxo-spiro/4h-1-benzopyran-4,4' -imidazolin/-2-karboximidderivat.

Country Status (10)

Country Link
US (1) US5036080A (fi)
EP (1) EP0336416A1 (fi)
JP (1) JP2708507B2 (fi)
KR (1) KR900016218A (fi)
CN (1) CN1038280A (fi)
FI (1) FI895831A0 (fi)
HU (1) HU203351B (fi)
PH (1) PH26817A (fi)
RU (1) RU1830068C (fi)
WO (1) WO1989009773A1 (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2002083649A1 (ja) * 2001-04-11 2004-08-05 千寿製薬株式会社 新規イミダゾリジンジオン誘導体およびその医薬用途
CN103787861B (zh) * 2012-10-30 2015-08-19 谷长安 一种硝酸氧化仲辛醇制备己酸的连续氧化方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127665A (en) * 1978-01-18 1978-11-28 Pfizer Inc. Thienohydantoin derivatives
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
JPS60158190A (ja) * 1984-01-30 1985-08-19 Eisai Co Ltd ヒダントイン誘導体およびその製法ならびにそれを含有する医薬
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―３―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
JPS63126881A (ja) * 1986-11-14 1988-05-30 Sanwa Kagaku Kenkyusho Co Ltd ヒダントイン誘導体、その塩、これらの製法並びに該化合物を有効成分とする糖尿病合併症の予防及び治療剤
JPS6357588A (ja) * 1986-08-28 1988-03-12 Sanwa Kagaku Kenkyusho Co Ltd ヒダントイン誘導体、その塩並びに該化合物を有効成分とする糖尿病合併症の予防及び治療剤

Also Published As

Publication number Publication date
EP0336416A1 (en) 1989-10-11
KR900016218A (ko) 1990-11-12
HUT53649A (en) 1990-11-28
PH26817A (en) 1992-11-05
JPH0222277A (ja) 1990-01-25
HU892236D0 (en) 1990-09-28
RU1830068C (ru) 1993-07-23
WO1989009773A1 (en) 1989-10-19
CN1038280A (zh) 1989-12-27
HU203351B (en) 1991-07-29
US5036080A (en) 1991-07-30
JP2708507B2 (ja) 1998-02-04

Similar Documents

Publication Publication Date Title
NO892218D0 (no) Fremgangsmaate for fremstilling av benzopyranderivater.
NO873091D0 (no) Fremgangsmaate for fremstilling av nye benzimidazolderivater.
NO893076L (no) Fremgangsmaate for fremstilling av aminomethyloxooxa-zolidinylarylbenzenderivater.
NO891951D0 (no) Fremgangsmaate for fremstilling av nye hydroksamat-derivater.
NO892936L (no) Fremgangsmaate for fremstilling av furanderivater.
NO894539L (no) Fremgangsmaate for fremstilling av nye 2'-halomethyliden-,2'-ethenyliden- og 2'-ethynylcytidin-, uriden og guanosinderivater.
NO892543L (no) Fremgangsmaate for fremstilling av nye neplanocinderivater.
NO901813L (no) Fremgangsmaate for fremstilling av nye tieno-triazolo-diazepin-derivater.
NO891588L (no) Fremgangsmaate for fremstilling av fosfonoalkylpurinderivater.
NO892977L (no) Fremgangsmaate for fremstilling av nye s-adenosylmethionin-derivater.
FI895831A0 (fi) Foerfarande foer framstaellning av (d)-6-fluor-2,3-dihydro-2',5'-dioxo-spiro/4h-1-benzopyran-4,4' -imidazolin/-2-karboximidderivat.
NO891381D0 (no) Fremgangsmaate for fremstilling av nye fluorfosfonatnukleotidderivater.
NO872393D0 (no) Fremgangsmaate for fremstilling av nye aralkylimidazolderivater.
NO894882L (no) Fremgangsmaate til fremstilling av (d)-6-fluor-2,3-dihydro-2',5'-diokso-spiro-(4h-1-benzopyran-4,4'-imidazolin)-2-karboksamid-derivater.
NO894707D0 (no) Fremgangsmaate for fremstilling av benzoxazinderivater.
NO871721L (no) Fremgangsmaate for fremstilling av nye ergolenderivater.
NO910564D0 (no) Fremgangsmaate for fremstilling av azaspiro(4,5)decan-7,9-dionderivater.
NO902293D0 (no) Fremgangsmaate for fremstilling av nye tiazepinderivater.
NO893428L (no) Fremgangsmaate for fremstilling av nye tieno(3',4'-4,5)-imidazo(2,1-b)tiazolderivater.
NO882279D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive endo-bicyklo (2,2,1) heptyl-adenosin-derivater.
ZA892507B (en) (d)-6-fluoro-2,3-dihydro-2',5'-dioxo-spiro(1h-1-benzopyran-4,4'-imidazolidine)-2-carboxamide derivatives,process for the preparation and use of the derivatives
NO894478D0 (no) Heterocykliske derivater av 1,2-difluorbenzen.
NO903254D0 (no) Fremgangsmaate for fremstilling av kinuklidin-derivater.
NO894476L (no) Derivater av 2,3-difluorhydrokinon.
NO913459L (no) Fremgangsmaate for fremstilling av 2',3'-dideoksy-2',3'-didehydronukleosider.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: SANWA KAGAKU KENKYUSHO CO., LTD.